M-BMAP-27 (1-16), Bomidin

General Information


DRACP ID  DRACP04395

Peptide Name   M-BMAP-27 (1-16), Bomidin

Sequence  MGRFKRFRKKFKKLFKKLS

Sequence Length  19

UniProt ID  P54228 

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial; Antiviral



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C118H197N35O21S

Absent amino acids  ACDEHINPQTVWY

Common amino acids  K

Mass  279536

Pl  12.84

Basic residues  10

Acidic residues  0

Hydrophobic residues  6

Net charge  10

Boman Index  -6196

Hydrophobicity  -112.11

Aliphatic Index  41.05

Half Life 
  Mammalian: 30 hour
  Yeast: >20 hour
  E.coli: >10 hour

Extinction Coefficient cystines  0

Absorbance 280nm  0

Polar residues  2

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 35663971

Title  Bomidin: An Optimized Antimicrobial Peptide With Broad Antiviral Activity Against Enveloped Viruses

Doi Not available

Year  2022

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  19366

DRACP is developed by Dr.Zheng's team.